This paper was developed with input from UNCTAD, WTO, and WHO experts. It considers the impact of tariffs on distributed R&D and manufacturing of health products. It stresses the importance of ensuring policy coherence – notably in relation to trade policies including border measures – in order to build biomanufacturing infrastructure and expertise across developing countries and regions.